Last reviewed: November 13, 2026.
SuperShot PRP is an add-on for EmCyte 30mL and 60mL PRP kits, made by Forever Labs, Inc. One 2 mL vial and one extra one-minute spin concentrate extracellular vesicles (EVs) from the patient’s own platelet-poor plasma and return them to the PRP. The kit is FDA 510(k) cleared for PRP preparation (BK251299). NewGen distributes it.
The SuperShot kit is FDA 510(k) cleared for PRP preparation (BK251299, Forever Labs, Inc., cleared 2026-03-11). FDA lists this clearance under the device name PlateletQuick PRP. FDA's stated use is the preparation of autologous platelet-rich-plasma that is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics. The clearance covers PRP preparation only; it is not an FDA approval and does not cover EV or exosome concentration or any treatment use. Source: FDA 510(k) record BK251299.
After your standard two-spin PRP preparation, add the SuperShot solution (a polyethylene glycol and dextran mixture) to the platelet-poor plasma and spin for one minute. The solution lets low-density EVs pellet at standard centrifuge speed. The pellet is resuspended into the PRP, and the supernatant, which carries the solution, is discarded. No new centrifuge and no new base kit. The process is 100% autologous: no donor or allogeneic material is used.
In a manufacturer lab comparison on split samples from one blood draw, SuperShot processing produced about 75% more extracellular vesicles than standard PRP from the same draw, manufacturer-reported lab data.
SuperShot works with EmCyte 30 mL and 60 mL PRP kits. The EVs are collected and used at the point of care.
The SuperShot kit is FDA 510(k) cleared for PRP preparation (BK251299, Forever Labs, Inc., cleared 2026-03-11). FDA lists this clearance under the device name PlateletQuick PRP. FDA's stated use is the preparation of autologous platelet-rich-plasma that is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics. The clearance covers PRP preparation only; it is not an FDA approval and does not cover EV or exosome concentration or any treatment use. Source: FDA 510(k) record BK251299.
The solution is discarded with the supernatant after the one-minute spin. Manufacturer testing measured amounts of polyethylene glycol and dextran remaining in the resuspended fraction.
SuperShot uses the patient’s own plasma. For context, FDA states: “There are currently no FDA-approved exosome products.” (FDA Public Safety Notification on Exosome Products, updated 2019-12-06.)
Use Get Pricing. NewGen does not post prices. We will email you a quote within one business day.
Get Pricing for SuperShot 2mL vials.
Autologous; FDA 510(k) clearance covers PRP preparation only. NewGen Biologics is a distributor of EmCyte products. SuperShot is made by Forever Labs, Inc.
